[LGND] QoQ Quarter Result on 31-Mar-2015 [#Q1]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
11-May-2015
Financial Year
2015
Quarter
31-Mar-2015 [#Q1]
Profit Trend
QoQ- -89.31%
YoY- -64.04%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Revenue 21,192 17,701 18,418 14,602 22,998 14,973 10,608 58.42%
PBT 5,826 7,284 22,292 -74 7,012 901 1,241 179.58%
Tax -515 -217,255 265 15 279 124 -47 391.18%
NP 6,341 199,165 23,564 754 7,055 1,280 1,592 150.63%
Tax Rate 8.84% 2,982.63% -1.19% - -3.98% -13.76% 3.79% -
Total Cost 14,851 -181,464 -5,146 13,848 15,943 13,693 9,016 39.34%
Ratio Analysis
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
NP Margin 29.92 1,125.16 127.94 5.16 30.68 8.55 15.01 58.18%
Per Share
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
EPS 0.32 10.01 1.19 0.04 0.35 0.06 0.08 151.34%
EPS Diluted 0.29 9.28 1.11 0.04 0.34 0.06 0.07 157.28%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.